Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Homerun Slides: Clinical presentation library Previous | All Articles This Week | Next
This article originally posted 01 August, 2011 and appeared in  MedicationMedication SlidesDiabetes Clinical Mastery Series Issue 44GLP-1 Receptor Agonist TherapyBest of GLP-1Special Edition - Keeping Patients on Track with GLP-1

GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 1 of 4

DCMS44_HS_Image

Topics covered include the clinical effects of GLP-1 agonists and DPP-4 inhibitors stemming from incretin action, and the role of glucagon in glucose intolerance and effects of GLP-1 based drugs on plasma glucagon....

Link to download (.ppt format): GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 1 of 4

Other sets in this series:

GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 2 of 4

GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 3 of 4

GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 4 of 4

Check out all of Diabetes In Control's slide collections at our new Clinical Presentations Library.

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 01 August, 2011 and appeared in  MedicationMedication SlidesDiabetes Clinical Mastery Series Issue 44GLP-1 Receptor Agonist TherapyBest of GLP-1Special Edition - Keeping Patients on Track with GLP-1

Past five issues: Diabetes Clinical Mastery Series Issue 137 | Issue 677 | Diabetes Clinical Mastery Series Issue 136 | Issue 676 | Diabetes Clinical Mastery Series Issue 135 |

 
Diabetes In Control Advertisers
 
Cast Your Vote
What test do you use to screen for prediabetes?

Navigate Diabetes In Control
Search Articles On Diabetes In Control